Plain-English translation of NCT02925819 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—a way to collect real-world information—for people with severe mitral valve disease who have been evaluated by a heart team and found not to be suitable for surgery. Researchers will gather information about your medical care, symptoms, test results, and how you're doing over 2 years. The goal is to better understand how doctors manage and treat people like you when surgery isn't an option.
Severe mitral valve disease can cause serious symptoms, but not everyone is healthy enough for surgery. This registry was created to understand what happens to patients in this situation—what treatments doctors use, how well patients do, and what outcomes to expect—so that future care can be improved.
You likely qualify if…
You likely don't qualify if…
You will have an initial medical evaluation including a physical exam, heart tests (ECG), blood work, and heart ultrasound scans. After that, your doctors will monitor you with phone calls at 6 months and in-person visits at 1 year and 2 years, with repeat heart ultrasound scans at those visits. Your medical team will continue to manage your care as usual while information about your treatment and health is collected.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
France
Sponsor
French Cardiology Society
Enrollment target
~500 participants
Started
October 2016
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jean-François OBADIA
Hospices Civils de Lyon
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.